Modulation of multiple molecular targets involved in inflammation and immune response

The phrase "Modulation of multiple molecular targets involved in inflammation and immune response" does not refer to a single, specific molecule, receptor, or protein. Instead, it describes a general therapeutic strategy that involves targeting several different molecular entities—such as receptors, enzymes, kinases, ion channels, and transcription factors—that play roles in the regulation of inflammation and immune system activity[1][2][3]. This approach is common in drug discovery for complex diseases like autoimmune disorders and chronic inflammatory conditions where multiple pathways contribute to pathology. Examples of such targets include protein tyrosine phosphatase 1B (PTP1B), spleen tyrosine kinase (SYK), T cell receptor components (e.g., CD3ɛ-Nck interaction), nuclear factor erythroid 2–related factor 2 (NRF2) pathway regulators like Keap1-NRF2 interaction inhibitors, receptor-interacting serine/threonine-protein kinase 1 (RIP1), toll-like receptors (TLRs), transient receptor potential vanilloid 1 channel (TRPV1), among others[1][2][3]. Because this entry refers broadly to a class of mechanisms rather than a defined target entity with an established name or abbreviation—and lacks specificity—it is not suitable for structured target annotation as requested.